Location History:
- St-Etienne-de-Lauzon, CA (2009 - 2011)
- St-Eustache, CA (2012 - 2016)
- Laval, CA (2013 - 2016)
Company Filing History:
3 out of 531 
3 out of 28 
3 out of 14 Years Active: 2009-2016
Title: Innovations and Contributions of Inventor Patrick Rheault
Introduction
Patrick Rheault is a distinguished inventor based in St-Eustache, Canada, known for his significant contributions to the field of vaccine development. With a remarkable portfolio of nine patents, Rheault has dedicated his career to advancing medical science through innovative inventions aimed at combating infectious diseases.
Latest Patents
Among Rheault's most notable patents is the development of recombinant respiratory syncytial virus (RSV) vaccines. This disclosure outlines methods for creating and utilizing recombinant RSV antigens, including immunogenic compositions that offer promising options for the treatment and prevention of RSV infections. Another significant patent focuses on Streptococcus pyogenes antigens and corresponding DNA fragments. This invention relates to antigens of the Group A Streptococcus bacterial pathogen, which serve as essential components in vaccines for therapeutic and preventive applications.
Career Highlights
Throughout his career, Patrick Rheault has made noteworthy contributions to major companies in the biotechnology sector. He has worked with GlaxoSmithKline Biologicals and ID Biomedical Corporation, where he has played a pivotal role in the research and development of groundbreaking vaccine technologies. His work has not only advanced scientific understanding but also has practical implications for public health.
Collaborations
Rheault has collaborated with notable colleagues in the field, including Denis Martin and Bernard R. Brodeur. These partnerships have fostered an environment of innovation and have helped propel multiple projects to fruition, demonstrating the power of teamwork in the pursuit of scientific discovery.
Conclusion
Patrick Rheault's dedication to innovation in vaccine development has resulted in significant advancements in the medical field. His impressive patent portfolio and collaborations highlight his role as a key inventor in addressing pressing health challenges. As he continues to contribute to the field, Rheault remains a prominent figure in the realm of biotechnological innovation.